Login Register Cart 0

Articles by Disease (Renal Cell Carcinoma)

Preclinical Evaluation of New Taxoids

Journal: Current Pharmaceutical Design
Volume: 7
Page: 1251-1257
Author(s): M. -C. Bissery

Chaperone-like Activity of alpha-Crystallin and Other Small Heat Shock Proteins

Journal: Current Protein & Peptide Science
Volume: 2
Page: 205-225
Author(s): Elena Ganea

Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 1
Page: 171-199
Author(s): Zafar H. israili

Targeting p53 in Cancer

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 1
Page: 151-161
Author(s): Patrick Chene

Modulation of P-Glycoprotein (PGP) Mediated Multidrug Resistance (MDR) Using Chemosensitizers: Recent Advances in the Design of Selective MDR Modulators

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 1
Page: 163-174
Author(s): Rajesh Krishna and Lawrence D. Mayer

Nonviral Gene Therapy

Journal: Current Gene Therapy
Volume: 1
Page: 201-226
Author(s): Song Li and Zheng Ma

The Use of Fas Ligand, TRAIL and Bax in Gene Therapy of Prostate Cancer

Journal: Current Gene Therapy
Volume: 1
Page: 123-136
Author(s): J. S. Norris, M. L. Hyer, C. Voelkel-Johnson, S. L. Lowe, S. Rubinchik and J-Y. Dong

Peptides as Carrier for Tumor Diagnosis and Treatment

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 1
Page: 71-93
Author(s): M. Langer and A. G. Beck-Sickinger

Receptor Tyrosine Kinases as Therapeutic Targets the Model of the MET Oncogene

Journal: Current Drug Targets
Volume: 2
Page: 41-55
Author(s): Paola Longati, Paolo M. Comoglio and Alberto Bardelli

Signal Transduction Pathways and Transcriptional Mechanisms as Targets for Prevention of Emergence of Multidrug Resistance in Human Cancer Cells

Journal: Current Drug Targets
Volume: 2
Page: 57-77
Author(s): Alexander A. Shtil